In this second part of the Journal scan of this issue, we provide a brief overview of the late-breaking trials presented at the American College of Cardiology (ACC) Conference held in Atlanta, Georgia, from April 6 to 8, 2024, and their relevance to our daily clinical practice. The trials are categorized under the following headings: F. Lipidology (VICTORION INITIATE, SHASTA2, Liberate HR, Bridge-TIMI 73A, AEGIS II,) G. Artificial Intelligence (TACTic, Be Active, Tele ACS) H.
No takes yet. Share an insight, caveat, or question.
Nagula et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: